name,category,termsATP-binding cassette, sub-family A (ABC1), member 4,INTERPRO[450003006$IPR003439:ABC transporter-like, 450003154$IPR003593:ATPase, AAA+ type, core, 450005395$IPR005951:Rim ABC transporter, 450016190$IPR017871:ABC transporter, conserved site]
ATP-binding cassette, sub-family A (ABC1), member 4,KEGG_PATHWAY[470038812$hsa02010:ABC transporters]
ATP-binding cassette, sub-family A (ABC1), member 4,OMIM_DISEASE[520001154$Cone-rod dystrophy 3, 520001951$Fundus flavimaculatus, 520003011$Macular degeneration, age-related, 2, 520004263$Retinal dystrophy, early-onset severe, 520004291$Retinitis pigmentosa-19, 520004672$Stargardt disease-1]
ATP-binding cassette, sub-family A (ABC1), member 4,SMART[760000335$SM00382:AAA]
ATP-binding cassette, sub-family A (ABC1), member 4,SP_PIR_KEYWORDS[790000032$age-related macular degeneration, 790000138$atp-binding, 790000356$complete proteome, 790000357$Cone-rod dystrophy, 790000446$disease mutation, 790000447$disulfide bond, 790000616$glycoprotein, 790000919$membrane, 790001063$nucleotide-binding, 790001212$polymorphism, 790001304$repeat, 790001316$retinitis pigmentosa, 790001377$sensory transduction, 790001438$Stargardt disease, 790001555$transmembrane, 790001558$transport, 790001622$vision]
ATP-binding cassette, sub-family A (ABC1), member 4,UP_SEQ_FEATURE[850057382$chain:Retinal-specific ATP-binding cassette transporter, 850102883$disulfide bond, 850102998$domain:ABC transporter 1, 850102999$domain:ABC transporter 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850106264$nucleotide phosphate-binding region:ATP 1, 850106265$nucleotide phosphate-binding region:ATP 2, 850117294$sequence conflict, 850117295$sequence variant, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
BRCA2 and CDKN1A interacting protein,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000258$cell cycle, 790000356$complete proteome, 790000452$DNA damage, 790000459$dna repair, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
BRCA2 and CDKN1A interacting protein,UP_SEQ_FEATURE[850008349$chain:BRCA2 and CDKN1A-interacting protein, 850106258$modified residue, 850112132$region of interest:Interaction with BRCA2, 850112169$region of interest:Interaction with CDKN1A, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
GA binding protein transcription factor, beta subunit 1,INTERPRO[450001870$IPR002110:Ankyrin]
GA binding protein transcription factor, beta subunit 1,PIR_SUPERFAMILY[630027779$PIRSF036345:nuclear respiratory factor-2 beta-1 chain]
GA binding protein transcription factor, beta subunit 1,SMART[760000220$SM00248:ANK]
GA binding protein transcription factor, beta subunit 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000086$ank repeat, 790000356$complete proteome, 790000445$direct protein sequencing, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001541$transcription factor, 790001543$transcription regulation]
GA binding protein transcription factor, beta subunit 1,UP_SEQ_FEATURE[850020362$chain:GA-binding protein subunit beta-1, 850106259$mutagenesis site, 850114911$region of interest:Transcription activation and HCFC1 interaction, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850115656$repeat:ANK 5, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
KiSS-1 metastasis-suppressor,SP_PIR_KEYWORDS[790000060$amidation, 790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790000445$direct protein sequencing, 790001162$phosphoprotein, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
KiSS-1 metastasis-suppressor,UP_SEQ_FEATURE[850031391$chain:Metastasis-suppressor KiSS-1, 850106258$modified residue, 850108035$peptide:Kisspeptin-10, 850108036$peptide:Kisspeptin-13, 850108037$peptide:Kisspeptin-14, 850108263$peptide:Metastin, 850111626$region of interest:Essential for receptor binding and receptor activation, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118076$site:Cleavage; by MMP2 and MMP9]
atlastin GTPase 1,INTERPRO[450014315$IPR015894:Guanylate-binding protein, N-terminal]
atlastin GTPase 1,OMIM_DISEASE[520004565$Spastic paraplegia-3A]
atlastin GTPase 1,SP_PIR_KEYWORDS[790000267$cell projection, 790000344$coiled coil, 790000356$complete proteome, 790000446$disease mutation, 790000499$endoplasmic reticulum, 790000624$golgi apparatus, 790000639$gtp-binding, 790000675$hereditary spastic paraplegia, 790000743$hydrolase, 790000919$membrane, 790001015$neurodegeneration, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001555$transmembrane]
atlastin GTPase 1,UP_SEQ_FEATURE[850006413$chain:Atlastin-1, 850106258$modified residue, 850106259$mutagenesis site, 850106296$nucleotide phosphate-binding region:GTP, 850114800$region of interest:Sufficient for membrane association, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
caspase recruitment domain family, member 8,INTERPRO[450001158$IPR001315:Caspase Recruitment, 450010009$IPR011029:DEATH-like]
caspase recruitment domain family, member 8,KEGG_PATHWAY[470038863$hsa04621:NOD-like receptor signaling pathway]
caspase recruitment domain family, member 8,SMART[760000101$SM00114:CARD]
caspase recruitment domain family, member 8,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001212$polymorphism]
caspase recruitment domain family, member 8,UP_SEQ_FEATURE[850009811$chain:Caspase recruitment domain-containing protein 8, 850103287$domain:CARD, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 17 open reading frame 44,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 17 open reading frame 44,UP_SEQ_FEATURE[850055234$chain:Putative uncharacterized protein C17orf44, 850117295$sequence variant]
chromosome 18 open reading frame 24,INTERPRO[450008915$IPR009829:Protein of unknown function DUF1395]
chromosome 18 open reading frame 24,PIR_SUPERFAMILY[630016448$PIRSF019945:PIRSF019945]
chromosome 18 open reading frame 24,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000258$cell cycle, 790000260$cell division, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000827$kinetochore, 790000960$microtubule, 790000973$mitosis, 790001212$polymorphism]
chromosome 18 open reading frame 24,UP_SEQ_FEATURE[850061988$chain:Spindle and kinetochore-associated protein 1, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
chromosome 6 open reading frame 203,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein]
chromosome 6 open reading frame 203,UP_SEQ_FEATURE[850074365$chain:Uncharacterized protein C6orf203, 850106258$modified residue]
chromosome 9 open reading frame 16,INTERPRO[450004832$IPR005374:Uncharacterised protein family UPF0184]
chromosome 9 open reading frame 16,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein]
chromosome 9 open reading frame 16,UP_SEQ_FEATURE[850088886$chain:UPF0184 protein C9orf16, 850106258$modified residue, 850117294$sequence conflict]
cutC copper transporter homolog (E. coli),INTERPRO[450005075$IPR005627:CutC]
cutC copper transporter homolog (E. coli),SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000371$copper, 790001212$polymorphism]
cutC copper transporter homolog (E. coli),UP_SEQ_FEATURE[850012558$chain:Copper homeostasis protein cutC homolog, 850117294$sequence conflict, 850117295$sequence variant]
hydroxysteroid (11-beta) dehydrogenase 1-like,INTERPRO[450001950$IPR002198:Short-chain dehydrogenase/reductase SDR, 450002088$IPR002347:Glucose/ribitol dehydrogenase, 450014426$IPR016040:NAD(P)-binding domain]
hydroxysteroid (11-beta) dehydrogenase 1-like,PIR_SUPERFAMILY[630000148$PIRSF000126:11beta-hydroxysteroid dehydrogenase]
hydroxysteroid (11-beta) dehydrogenase 1-like,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001008$nadp, 790001092$oxidoreductase, 790001363$Secreted, 790001405$signal]
hydroxysteroid (11-beta) dehydrogenase 1-like,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000555$binding site:Substrate, 850025270$chain:Hydroxysteroid 11-beta-dehydrogenase 1- like protein, 850106307$nucleotide phosphate-binding region:NADP, 850117814$signal peptide, 850118574$splice variant]
insulin-like 6,INTERPRO[450004307$IPR004825:Insulin/IGF/relaxin, 450015420$IPR017100:Insulin-like peptide 6]
insulin-like 6,PIR_SUPERFAMILY[630028563$PIRSF037062:insulin-like peptide 6, 630028564$PIRSF037062:Insulin-like_peptide_6]
insulin-like 6,SMART[760000068$SM00078:IlGF]
insulin-like 6,SP_PIR_KEYWORDS[790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790000447$disulfide bond, 790000708$hormone, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
insulin-like 6,UP_SEQ_FEATURE[850026192$chain:Insulin-like peptide INSL6, 850102883$disulfide bond, 850107934$peptide:Insulin-like peptide INSL6 A chain, 850107935$peptide:Insulin-like peptide INSL6 B chain, 850109655$propeptide:Connecting peptide, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
interleukin 15 receptor, alpha,INTERPRO[450000373$IPR000436:Sushi/SCR/CCP, 450011699$IPR013032:EGF-like region, conserved site]
interleukin 15 receptor, alpha,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038866$hsa04630:Jak-STAT signaling pathway, 470038874$hsa04672:Intestinal immune network for IgA production]
interleukin 15 receptor, alpha,SMART[760000024$SM00032:CCP]
interleukin 15 receptor, alpha,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000447$disulfide bond, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000624$golgi apparatus, 790000919$membrane, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001363$Secreted, 790001405$signal, 790001471$sushi, 790001555$transmembrane]
interleukin 15 receptor, alpha,UP_SEQ_FEATURE[850026532$chain:Interleukin-15 receptor subunit alpha, 850061336$chain:Soluble interleukin-15 receptor subunit alpha, 850102883$disulfide bond, 850105415$domain:Sushi, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
leucine rich repeat containing 8 family, member D,INTERPRO[450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype]
leucine rich repeat containing 8 family, member D,SMART[760000333$SM00369:LRR_TYP]
leucine rich repeat containing 8 family, member D,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000853$leucine-rich repeat, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane]
leucine rich repeat containing 8 family, member D,UP_SEQ_FEATURE[850028432$chain:Leucine-rich repeat-containing protein 8D, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850116308$repeat:LRR 1, 850116309$repeat:LRR 10, 850116310$repeat:LRR 11, 850116311$repeat:LRR 12, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850116346$repeat:LRR 9, 850117295$sequence variant, 850118623$transmembrane region]
microseminoprotein, beta-,INTERPRO[450007989$IPR008735:Beta-microseminoprotein]
microseminoprotein, beta-,OMIM_DISEASE[520003403$Multiple loci identified in a genome-wide association study of prostate cancer, 520003407$Multiple newly identified loci associated with prostate cancer susceptibility, 520004124$Prostate cancer, hereditary, 13]
microseminoprotein, beta-,PIR_SUPERFAMILY[630002659$PIRSF002542:beta-microseminoprotein]
microseminoprotein, beta-,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790001212$polymorphism, 790001363$Secreted, 790001374$semen, 790001405$signal]
microseminoprotein, beta-,UP_SEQ_FEATURE[850007871$chain:Beta-microseminoprotein, 850102883$disulfide bond, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118624$turn]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10,INTERPRO[450001740$IPR001965:Zinc finger, PHD-type, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10,OMIM_DISEASE[520002837$Leukemia, acute myeloid, 520002853$Leukemia, acute T-cell lymphoblastic]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10,SMART[760000221$SM00249:PHD]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10,SP_PIR_KEYWORDS[790000316$chromosomal rearrangement, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001271$Proto-oncogene, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10,UP_SEQ_FEATURE[850045001$chain:Protein AF-10, 850102511$compositionally biased region:Glu/Lys-rich, 850102581$compositionally biased region:Poly-Ser, 850104712$domain:Leucine-zipper, 850106258$modified residue, 850111458$region of interest:DNA-binding, 850112338$region of interest:Interaction with FSTL3, 850114622$region of interest:Self-association, 850114898$region of interest:Transactivation domain, 850118433$site:MLL fusion point (in acute myeloid leukemia patient A), 850118434$site:MLL fusion point (in acute myeloid leukemia patient B), 850118435$site:MLL fusion point (in acute myeloid leukemia patient C), 850118762$zinc finger region:C4-type, 850118878$zinc finger region:PHD-type 1, 850118880$zinc finger region:PHD-type 2]
neuroguidin, EIF4E binding protein,INTERPRO[450006519$IPR007146:Sas10/Utp3/C1D]
neuroguidin, EIF4E binding protein,PIR_SUPERFAMILY[630023633$PIRSF031081:PIRSF031081]
neuroguidin, EIF4E binding protein,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000267$cell projection, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001307$repressor, 790001551$translation regulation]
neuroguidin, EIF4E binding protein,UP_SEQ_FEATURE[850033995$chain:Neuroguidin, 850106258$modified residue, 850113608$region of interest:Necessary for interaction with EIF4E, 850117295$sequence variant, 850118574$splice variant]
nuclear receptor subfamily 1, group D, member 2,INTERPRO[450000278$IPR000324:Vitamin D receptor, 450000459$IPR000536:Nuclear hormone receptor, ligand-binding, core, 450001442$IPR001628:Zinc finger, nuclear hormone receptor-type, 450001527$IPR001723:Steroid hormone receptor, 450008168$IPR008946:Nuclear hormone receptor, ligand-binding, 450011732$IPR013088:Zinc finger, NHR/GATA-type]
nuclear receptor subfamily 1, group D, member 2,SMART[760000350$SM00399:ZnF_C4, 760000376$SM00430:HOLI]
nuclear receptor subfamily 1, group D, member 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
nuclear receptor subfamily 1, group D, member 2,UP_SEQ_FEATURE[850035044$chain:Nuclear receptor subfamily 1 group D member 2, 850102581$compositionally biased region:Poly-Ser, 850102946$DNA-binding region:Nuclear receptor, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn, 850118866$zinc finger region:NR C4-type]
phosphoseryl-tRNA kinase,INTERPRO[450012262$IPR013641:Chromatin associated protein KTI12, 450018255$IPR020028:L-seryl-tRNA(Sec)kinase, eukaryote]
phosphoseryl-tRNA kinase,KEGG_PATHWAY[470038807$hsa00970:Aminoacyl-tRNA biosynthesis]
phosphoseryl-tRNA kinase,PIR_SUPERFAMILY[630028581$PIRSF037082:PIRSF037082]
phosphoseryl-tRNA kinase,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000825$kinase, 790000899$magnesium, 790001063$nucleotide-binding, 790001212$polymorphism, 790001255$protein biosynthesis, 790001547$transferase]
phosphoseryl-tRNA kinase,UP_SEQ_FEATURE[850027795$chain:L-seryl-tRNA(Sec) kinase, 850106263$nucleotide phosphate-binding region:ATP, 850117295$sequence variant, 850118574$splice variant]
ribonuclease T2,INTERPRO[450001394$IPR001568:Ribonuclease T2, 450016476$IPR018188:Ribonuclease T2, active site]
ribonuclease T2,PIR_SUPERFAMILY[630001172$PIRSF001016:ribonuclease, T2 type]
ribonuclease T2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000498$Endonuclease, 790000616$glycoprotein, 790000743$hydrolase, 790001049$nuclease, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
ribonuclease T2,UP_SEQ_FEATURE[850057788$chain:Ribonuclease T2, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
ring finger protein 26,INTERPRO[450001628$IPR001841:Zinc finger, RING-type, 450016222$IPR017907:Zinc finger, RING-type, conserved site, 450017227$IPR018957:Zinc finger, C3HC4 RING-type]
ring finger protein 26,SMART[760000158$SM00184:RING]
ring finger protein 26,SP_PIR_KEYWORDS[790000356$complete proteome, 790000852$leucine zipper, 790000937$metal-binding, 790001591$ubiquitination, 790001648$zinc, 790001651$zinc-finger]
ring finger protein 26,UP_SEQ_FEATURE[850058215$chain:RING finger protein 26, 850102552$compositionally biased region:Leu-rich, 850118911$zinc finger region:RING-type]
transmembrane protein 50A,INTERPRO[450007266$IPR007919:Uncharacterised protein family UPF0220]
transmembrane protein 50A,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
transmembrane protein 50A,UP_SEQ_FEATURE[850066186$chain:Transmembrane protein 50A, 850106258$modified residue, 850117295$sequence variant, 850118623$transmembrane region]
tumor necrosis factor receptor superfamily, member 4,BIOCARTA[30000212$h_ox40Pathway:OX40 Signaling Pathway]
tumor necrosis factor receptor superfamily, member 4,INTERPRO[450001212$IPR001368:TNFR/CD27/30/40/95 cysteine-rich region]
tumor necrosis factor receptor superfamily, member 4,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction]
tumor necrosis factor receptor superfamily, member 4,PIR_SUPERFAMILY[630030267$PIRSF038813:tumor necrosis factor receptor superfamily member 4]
tumor necrosis factor receptor superfamily, member 4,SMART[760000181$SM00208:TNFR]
tumor necrosis factor receptor superfamily, member 4,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
tumor necrosis factor receptor superfamily, member 4,UP_SEQ_FEATURE[850067216$chain:Tumor necrosis factor receptor superfamily member 4, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850117108$repeat:TNFR-Cys 1, 850117109$repeat:TNFR-Cys 2, 850117112$repeat:TNFR-Cys 3; truncated, 850117113$repeat:TNFR-Cys 4, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
